Biotech VC Forbion raises record $2.6B to support 30 ‘high-potential’ companies

PartnershipPositive

AI Analysis

Summary

Forbion raised a record $2.6B for its venture fund to support 30 high-potential biotech companies. Portfolio company Gate Bioscience expanded its partnership with Eli Lilly with an up to $870 million deal extension.

Outcome Details

Gate Bioscience extension deal with Eli Lilly valued at up to $870 million

Importance:6/10

Sentiment:

0.70

venture_capitalfundraisingpartnershiplicensing

Related Companies

$FFPH $LLY

Read the original article

Published by BioSpace on October 7, 2026 12:24 PM

Read Original